Model‐based assessment of variability in isoniazid pharmacokinetics and metabolism in patients co‐infected with tuberculosis and HIV: implications for a novel dosing strategy. 

Sundell, J., Bienvenu, E., Janzén, D., Birgersson, S., Äbelö, A., & Ashton, M.